This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Apr;79(4):466-467.

doi: 10.1016/j.eururo.2020.11.022. Epub 2020 Dec 24.

Evidence for Focal Grade Group Progression in Low-risk Prostate Cancer

Michael Fraser¹

Affiliations

PMID: 33357993
DOI: 10.1016/j.eururo.2020.11.022

Editorial

Evidence for Focal Grade Group Progression in Low-risk Prostate Cancer

Michael Fraser. Eur Urol. 2021 Apr.

. 2021 Apr;79(4):466-467.

doi: 10.1016/j.eururo.2020.11.022. Epub 2020 Dec 24.

Author

Michael Fraser¹

Affiliation

¹ Princess Margaret Hospital Cancer Centre, Toronto, Canada. Electronic address: michael.fraser@cpcgene.com.

PMID: 33357993
DOI: 10.1016/j.eururo.2020.11.022

No abstract available

PubMed Disclaimer

Comment on

Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study.
Salami SS, Tosoian JJ, Nallandhighal S, Jones TA Jr, Brockman S, Elkhoury FF, Bazzi S, Plouffe KR, Siddiqui J, Liu CJ, Kunju LP, Morgan TM, Natarajan S, Boonstra PS, Sumida L, Tomlins SA, Udager AM, Sisk AE Jr, Marks LS, Palapattu GS. Salami SS, et al. Eur Urol. 2021 Apr;79(4):456-465. doi: 10.1016/j.eururo.2020.06.041. Epub 2020 Jul 3. Eur Urol. 2021. PMID: 32631746 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information